← All stocks

Adicet Bio, Inc.

ACET Net buying

CIK 0001720580 #4407 in the set updated 18 Sep 2026

Bought (12 mo)

$6.60M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$674.85K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$674.85K

4 of 4 sales

Net

+$5.93M

+$5.93M against sales at will

By person

11 insiders · 9 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

ORBIMED ADVISORS LLC entity

10% owner

$5.00M (2)

$674.85K (4)

+$4.33M

$0.00

—

RA CAPITAL MANAGEMENT, L.P. entity

10% owner

$1.60M (3)

—

+$1.60M

932,624

$6.08M

−2.8%

Klickstein Lloyd

Chief Medical Officer

—

108,566

$707.85K

+5.7%

DUBIN STEVE

Director

—

22,700

$148.00K

+35.1%

Chodakewitz Jeffrey

Director

—

17,700

$115.40K

+50.0%

Sinclair Andrew

Director

—

17,700

$115.40K

+50.0%

Peng Katie

Director

—

11,800

$76.94K

+100.0%

Schor Chen

President & CEO

—

6,820

$44.47K

−81.4%

Harvey Brian Nicholas

Chief Financial Officer

—

5,145

$33.55K

−64.4%

Healey Don

Chief Technology Officer

—

3,452

$22.51K

−72.5%

Aftab Blake

Chief Scientific Officer

—

2,981

$19.44K

−69.5%

No percentages here. This company's share count has moved by a factor of 16.4 over the window, from 9,361,490 to 153,255,581 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 253,371

History held since 30 Jan 2018